A Novel Five Gene Signature Derived from Stem-Like Side Population Cells Predicts Overall and Recurrence-Free Survival in NSCLC

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Perumal, Deepak ^a   Singh, Sandeep ^a,b   Yoder, Sean J ^a   Bloom, Gregory C ^a   Chellappan, Srikumar P ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF BIOMEDICAL GENOMICS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AURKB GENE; BRRN1 GENE; CANCER PATIENT; CANCER RECURRENCE; CANCER RELAPSE; CANCER STEM CELL; CANCER SURVIVAL; CDK1 GENE; CELL ISOLATION; CELL POPULATION; CHROMOSOME CONDENSATION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DOWN REGULATION; FUS GENE; GENE; GENE CONTROL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PREDICTION; RECURRENCE FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMS BIOLOGY; TOP2A GENE; UPREGULATION;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; HUMANS; LUNG NEOPLASMS; NEOPLASTIC STEM CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTOME;

EID: 84865600696     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043589     Document Type: Article

References (55)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA: A Cancer Journal for Clinicians 61: 69-90.
2. Hoffman PC, Mauer AM, Vokes EE, (2000) Lung cancer. The Lancet 355: 479-485.
3. Subramanian J, Simon R, (2010) Gene Expression-Based Prognostic Signatures in Lung Cancer: Ready for Clinical Use? Journal of the National Cancer Institute 102: 464-474.
4. Guo NL, Wan Y-W, Tosun K, Lin H, Msiska Z, et al. (2008) Confirmation of Gene Expression-Based Prediction of Survival in Non-Small Cell Lung Cancer. Clinical Cancer Research 14: 8213-8220.
5. Dalton WS, Friend SH, (2006) Cancer Biomarkers-An Invitation to the Table. Science 312: 1165-1168.
6. Baker SG, Kramer BS, Srivastava S, (2002) Markers for early detection of cancer: Statistical guidelines for nested case-control studies. BMC Medical Research Methodology 2.
7. Beer DG, Kardia SLR, Huang C-C, Giordano TJ, Levin AM, et al. (2002) Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8: 816-824.
8. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, et al. (2001) Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proceedings of the National Academy of Sciences 98: 13790-13795.
9. Endoh H, Tomida S, Yatabe Y, Konishi H, Osada H, et al. (2004) Prognostic Model of Pulmonary Adenocarcinoma by Expression Profiling of Eight Genes As Determined by Quantitative Real-Time Reverse Transcriptase Polymerase Chain Reaction. Journal of Clinical Oncology 22: 811-819.
10. Hoheisel JD, (2006) Microarray technology: beyond transcript profiling and genotype analysis. Nat Rev Genet 7: 200-210.
11. Chen H-Y, Yu S-L, Chen C-H, Chang G-C, Chen C-Y, et al. (2007) A Five-Gene Signature and Clinical Outcome in Non-Small-Cell Lung Cancer. New England Journal of Medicine 356: 11-20.
12. Glinsky GV, Berezovska O, Glinskii AB, (2005) Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. The Journal of Clinical Investigation 115: 1503-1521.
13. Tinker AV, Boussioutas A, Bowtell DDL, (2006) The challenges of gene expression microarrays for the study of human cancer. Cancer Cell 9: 333-339.
14. Michiels S, Koscielny S, Hill C, (2005) Prediction of cancer outcome with microarrays: a multiple random validation strategy. The Lancet 365: 488-492.
15. Segal E, Friedman N, Kaminski N, Regev A, Koller D, (2005) From signatures to models: understanding cancer using microarrays. Nat Genet 37: S38-S45.
16. Reya T, Morrison SJ, Clarke MF, Weissman IL, (2001) Stem cells, cancer, and cancer stem cells. Nature 414: 105-111.
17. Zhou S, Schuetz JD, Bunting KD, Colapietro A-M, Sampath J, et al. (2001) The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7: 1028-1034.
18. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, et al. (2004) A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proceedings of the National Academy of Sciences of the United States of America 101: 14228-14233.
19. Ho MM, Ng AV, Lam S, Hung JY, (2007) Side Population in Human Lung Cancer Cell Lines and Tumors Is Enriched with Stem-like Cancer Cells. Cancer Research 67: 4827-4833.
20. Shedden K, Taylor JMG, Enkemann SA, Tsao M-S, Yeatman TJ, et al. (2008) Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med 14: 822-827.
21. Lee E-S, Son D-S, Kim S-H, Lee J, Jo J, et al. (2008) Prediction of Recurrence-Free Survival in Postoperative Non-Small Cell Lung Cancer Patients by Using an Integrated Model of Clinical Information and Gene Expression. Clinical Cancer Research 14: 7397-7404.
22. Fatoba ST, Okorokov AL, (2011) Human SIRT1 associates with mitotic chromatin and contributes to chromosomal condensation. Cell Cycle 10: 2317-2322.
23. Wechsler T, Newman S, West SC, (2011) Aberrant chromosome morphology in human cells defective for Holliday junction resolution. Nature 471: 642-646.
24. Stevens J, Abdallah B, Regan S, Liu G, Bremer S, et al. (2010) Comparison of mitotic cell death by chromosome fragmentation to premature chromosome condensation. Molecular Cytogenetics 3: 20.
25. Stevens JB, Liu G, Bremer SW, Ye KJ, Xu W, et al. (2007) Mitotic Cell Death by Chromosome Fragmentation. Cancer Research 67: 7686-7694.
26. Huang E, Ishida S, Pittman J, Dressman H, Bild A, et al. (2003) Gene expression phenotypic models that predict the activity of oncogenic pathways. Nat Genet 34: 226-230.
27. Raponi M, Zhang Y, Yu J, Chen G, Lee G, et al. (2006) Gene Expression Signatures for Predicting Prognosis of Squamous Cell and Adenocarcinomas of the Lung. Cancer Research 66: 7466-7472.
28. Bild AH, Yao G, Chang JT, Wang Q, Potti A, et al. (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439: 353-357.
29. Dean M, Fojo T, Bates S, (2005) Tumour stem cells and drug resistance. Nat Rev Cancer 5: 275-284.
30. Yang P, Sun Z, Aubry MC, Kosari F, Bamlet W, et al. (2004) Study design considerations in clinical outcome research of lung cancer using microarray analysis. Lung Cancer 46: 215-226.
31. Kalluri R, Weinberg RA, (2009) The basics of epithelial-mesenchymal transition. The Journal of Clinical Investigation 119: 1420-1428.
32. Mani SA, Guo W, Liao M-J, Eaton EN, Ayyanan A, et al. (2008) The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells. Cell 133: 704-715.
33. Chikaishi Y, Uramoto H, Tanaka F, (2011) The EMT Status in the Primary Tumor Does Not Predict Postoperative Recurrence or Disease-free Survival in Lung Adenocarcinoma. Anticancer Research 31: 4451-4456.
34. Xu K, Cui J, Olman V, Yang Q, Puett D, et al. (2010) A Comparative Analysis of Gene-Expression Data of Multiple Cancer Types. PLoS ONE 5: e13696.
35. Varis A, Zaika A, Puolakkainen P, Nagy B, Madrigal I, et al. (2004) Coamplified and overexpressed genes at ERBB2 locus in gastric cancer. International Journal of Cancer 109: 548-553.
36. Koren R, Rath-Wolfson L, Ram E, Itzhac OB, Schachter B, et al. (2004) Prognostic value of Topoisomerase II in female breast cancer. Oncology Reports 12: 915-919.
37. Chekerov R, Klamany I, Zafrakasz M, Konsgen D, Mustea A, et al. (2006) Altered Expression Pattern of Topoisomerase IIa in Ovarian Tumor Epithelial and Stromal Cells after Platinum-Based Chemotherapy. Neoplasia 8: 38-45.
38. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, et al. (2004) Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proceedings of the National Academy of Sciences of the United States of America 101: 9309-9314.
39. Kanta SY, Yamane T, Dobashi Y, Mitsui F, Kono K, et al. (2006) Topoisomerase IIα gene amplification in gastric carcinomas: correlation with the HER2 gene. An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study. Human Pathology 37: 1333-1343.
40. Tanaka T, Tanimoto K, Otani K, Satoh K, Ohtaki M, et al. (2004) Concise prediction models of anticancer efficacy of 8 drugs using expression data from 12 selected genes. International Journal of Cancer 111: 617-626.
41. Landi MT, Dracheva T, Rotunno M, Figueroa JD, Liu H, et al. (2008) Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival. PLoS ONE 3: e1651.
42. Kufer TA, Silljé HHW, Körner R, Gruss OJ, Meraldi P, et al. (2002) Human TPX2 is required for targeting Aurora-A kinase to the spindle. The Journal of Cell Biology 158: 617-623.
43. Shuda K, Schindler K, Ma J, Schultz RM, Donovan PJ, (2009) Aurora kinase B modulates chromosome alignment in mouse oocytes. Molecular Reproduction and Development 76: 1094-1105.
44. Fu J, Bian M, Jiang Q, Zhang C, (2007) Roles of Aurora Kinases in Mitosis and Tumorigenesis. Molecular Cancer Research 5: 1-10.
45. Winslow MM, Dayton TL, Verhaak RGW, Kim-Kiselak C, Snyder EL, et al. (2011) Suppression of lung adenocarcinoma progression by Nkx2-1. Nature 473: 101-104.
46. Nguyen DX, Chiang AC, Zhang XHF, Kim JY, Kris MG, et al. (2009) WNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis. Cell 138: 51-62.
47. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC, (1996) Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. The Journal of Experimental Medicine 183: 1797-1806.
48. Lafferty-Whyte K, Cairney CJ, Jamieson NB, Oien KA, Keith WN, (2009) Pathway analysis of senescence-associated miRNA targets reveals common processes to different senescence induction mechanisms. Biochimica et Biophysica Acta (BBA)- Molecular Basis of Disease 1792: 341-352.
49. Marotta LLC, Almendro V, Marusyk A, Shipitsin M, Schemme J, et al. (2011) The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24- stem cell-like breast cancer cells in human tumors. The Journal of Clinical Investigation 121: 2723-2735.
50. Yi JM, Dhir M, Van Neste L, Downing SR, Jeschke J, et al. (2011) Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer. Clinical Cancer Research 17: 1535-1545.
51. Livak KJ, Schmittgen TD, (2001) Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2-ΔΔCT Method. Methods 25: 402-408.
52. Reimers M, Carey VJ (2006) Bioconductor: An Open Source Framework for Bioinformatics and Computational Biology. In: Alan K, Brian O, editors. Methods in Enzymology: Academic Press. pp. 119-134.
53. Ringner M, (2008) What is principal component analysis? Nat Biotech 26: 303-304.
54. Navab R, Strumpf D, Bandarchi B, Zhu C-Q, Pintilie M, et al. (2011) Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer. Proceedings of the National Academy of Sciences.
55. R, Development Core Team (2008) A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0.